J&J Covid-19 vaccine production hits snag, supplies may be delayed, report says

A Politico report said Johnson & Johnson’s Covid-19 vaccine has hit a production snag, which may delay the delivery of millions of doses by at least two months. J&J, which vowed to make 12 million of the single-dose jabs available by February-end, told health officials that it would be difficult to meet its supply target. However, a company representative said there was no production slowdown.